Stephanie Gentile

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Cooley advised Jump Crypto as a sponsor in connection with $1.65 billion in cash and stablecoin commitments for a private investment in public equity (PIPE) offering by Forward Industries, a global design company serving top-tier medical and technology companies, to initiate a Solana-focused digital asset treasury strategy, aligning Forward Industries with the fast-growing Solana ecosystem.

Cooley advised TBO, a leading global travel distribution platform, on its agreement to acquire Classic Vacations from Arizona-based investment firm, the Najafi Companies.

Cooley advised CHARM Therapeutics, a biotechnology company pioneering the next generation of precision oncology treatments through its proprietary artificial intelligence-driven drug discovery platform, on its $80 million Series B financing, to advance its next-generation menin inhibitor into clinical development.